View in EDS HTML Full Text PDF Full Text

Engineering TCR-directed T-cells for the treatment of multiple myeloma.

Saved in:
Bibliographic Details
Title: Engineering TCR-directed T-cells for the treatment of multiple myeloma.
Authors: Mubin N; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States., Ignatz-Hoover JJ; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.; Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States., Driscoll JJ; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.; Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Mar 31; Vol. 17, pp. 1755096. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41988204
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineering TCR-directed T-cells for the treatment of multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mubin+N%22">Mubin N</searchLink>; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Ignatz-Hoover+JJ%22">Ignatz-Hoover JJ</searchLink>; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.; Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Driscoll+JJ%22">Driscoll JJ</searchLink>; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.; Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Mar 31; Vol. 17, pp. 1755096. <i>Date of Electronic Publication: </i>2026 Mar 31 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41988204
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1755096
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1755096
    Titles:
      – TitleFull: Engineering TCR-directed T-cells for the treatment of multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mubin N
      – PersonEntity:
          Name:
            NameFull: Ignatz-Hoover JJ
      – PersonEntity:
          Name:
            NameFull: Driscoll JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2026 Mar 31
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1